Results 51 to 60 of about 13,452 (195)
Cancer Medicine, 2019 Background Pancreatic ductal adenocarcinoma (PDAC) accounts for >90% of pancreatic malignancies, and has median survival of
Rubin Jiao +9 more
doaj +1 more source
Advanced Science, 2023 Radiotherapy (RT), a widely used clinical treatment modality for cancer, uses high‐energy irradiation for reactive oxygen species (ROS) production and DNA damage.
Liang Xiao +6 more
doaj +1 more source
Radioimmunotherapy of Pancreatic Ductal Adenocarcinoma: A Review of the Current Status of Literature
Cancers, 2020 Pancreatic ductal adenocarcinoma (PDAC) has long been associated with low survival rates. A lack of accurate diagnostic tests and limited treatment options contribute to the poor prognosis of PDAC.
Ashleigh Hull +5 more
semanticscholar +1 more source
RADIOIMMUNOTHERAPY IN THE TREATMENT OF MALIGNANCIES
Сибирский онкологический журнал, 2016 This review presents information about one of the promising areas of targeted therapy in modern oncology, which is called radioimmunotherapy. Particular attention is paid to the possibility of clinical application of this type of systemic treatment for ...
V. I. Chernov +4 more
doaj +1 more source
Blood and Lymphatic Cancer: Targets and Therapy, 2023 Jing Wang,1 Firas Baidoun,2 Han W Tun,2 Muhamad Alhaj Moustafa2 1Department of Internal Medicine, Mayo Clinic Florida, Jacksonville, FL, 32224, USA; 2Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224 ...
Wang J +3 more
doaj
From netrin‐1‐targeted SPECT/CT to internal radiotherapy for management of advanced solid tumors
EMBO Molecular Medicine, 2023 Targeted radionuclide therapy is a revolutionary tool for the treatment of highly spread metastatic cancers. Most current approaches rely on the use of vectors to deliver radionuclides to tumor cells, targeting membrane‐bound cancer‐specific moieties ...
David Kryza +20 more
doaj +1 more source
Clinical Cancer Research, 2018 Purpose: Interest in targeted alpha-therapy has surged due to α-particles' high cytotoxicity. However, the widespread clinical use of this approach could be limited by on-/off-target toxicities.
S. Poty +8 more
semanticscholar +1 more source
Combination Radioimmunotherapy Strategies for Solid Tumors
International Journal of Molecular Sciences, 2019 Combination radioimmunotherapy is an emerging approach for the treatment of solid tumors where radio immunotherapy alone has proven to be reasonably ineffective. Radioimmunotherapy (RIT) using monoclonal antibodies (mAbs) labeled with radionuclides is an
Javeria Zaheer +4 more
semanticscholar +1 more source
Pharmaceutics, 2019 Melanoma is a cancer with increasing incidence and there is a need for alternatives to immunotherapy within effective approaches to treatment of metastatic melanoma.
Kevin J. H. Allen +6 more
doaj +1 more source
212Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study
Journal of Nuclear Medicine, 2019 Multiple myeloma (MM) is a plasma cell cancer and represents the second most frequent hematologic malignancy. Despite new treatments and protocols, including high-dose chemotherapy associated with autologous stem cell transplantation, the prognosis of MM
I. Quelven +8 more
semanticscholar +1 more source